Health and biomedical research programming
3 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- AGENCE NATIONALE DE LA RECHERCHE
France's national research funding agency, coordinating transnational ERA-NET programs across environment, health, food security, and quantum technologies.
“9 health-sector projects including E-Rare-3 (rare diseases), JPco-fuND (neurodegenerative diseases), JPI-EC-AMR (antimicrobial resistance), and ERACoSysMed (systems medicine).”
FR71 projects - Ministrstvo za izobrazevanje, znanost in sport
Slovenia's science ministry co-funding transnational ERA-NET research calls in quantum technologies, raw materials, health, and humanities across Europe.
“Co-funded transnational health calls via TRANSCAN-2, ERACoSysMed, ERA-CVD, ERA PerMed, and JPCOFUND2 covering cancer, cardiovascular, personalised medicine, and neurodegeneration.”
SI29 projects - LATVIJAS ZINATNES PADOME
Latvia's national research funding agency, co-funding transnational ERA-NET calls across health, environment, food, energy, and quantum technologies.
“Seven health-sector projects covering rare diseases (EJP RD), neurodegenerative diseases (JPCOFUND2, NEURON Cofund2), cancer (TRANSCAN-3), personalized medicine (ERA PerMed), and antimicrobial resistance (JPIAMR-ACTION).”
PrimaryLV22 projects